Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus

The objective of this study was to evaluate the effect of strict supragingival biofilm control on serum inflammatory markers and on periodontal clinical parameters in type 2 diabetes mellitus (T2DM) patients with chronic severe periodontitis. Twenty-four individuals with T2DM and periodontitis were randomly allocated to two treatment groups. The supragingival therapy group (ST, n = 12) received supragingival scaling, whereas the intensive therapy group (IT, n = 12) underwent supra- and subgingival scaling, as well as root planing. Patients from both groups received professional oral hygiene instructions every month. Data regarding visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), probing pocket depth (PPD), clinical attachment level (CAL), serum levels of interleukin (IL)-6, IL-17A, IL-8, tumor necrosis factor α (TNF-α), monocyte chemoattractant protein (MCP)-1 enzyme-linked immunosorbent assay (ELISA), and glycated hemoglobin (HbA1c) levels were obtained at baseline and at 6 months post-therapy. Both therapies resulted in the improvement of almost all clinical periodontal parameters (p < 0.05). There were no differences in TNF-α, IL-8, IL-17A and HbA1c levels in either group (p >0.05), between the two periods. However, MCP-1 levels were significantly reduced in both the ST (p = 0.034) and the IT (p = 0.016) groups, whereas the serum IL-6 levels were significantly reduced only in the IT group (p = 0.001). Strict control of supragingival biofilm has a limited effect on systemic inflammatory markers, and a moderate effect on periodontal clinical parameters.

Saved in:
Bibliographic Details
Main Authors: ARTESE,Hilana Paula Carillo, LONGO,Priscila Larcher, GOMES,Giovane Hisse, MAYER,Marcia Pinto Alves, ROMITO,Giuseppe Alexandre
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pesquisa Odontológica - SBPqO 2015
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242015000100266
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1806-83242015000100266
record_format ojs
spelling oai:scielo:S1806-832420150001002662018-09-17Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitusARTESE,Hilana Paula CarilloLONGO,Priscila LarcherGOMES,Giovane HisseMAYER,Marcia Pinto AlvesROMITO,Giuseppe Alexandre Diabetes Mellitus Periodontitis Cytokines The objective of this study was to evaluate the effect of strict supragingival biofilm control on serum inflammatory markers and on periodontal clinical parameters in type 2 diabetes mellitus (T2DM) patients with chronic severe periodontitis. Twenty-four individuals with T2DM and periodontitis were randomly allocated to two treatment groups. The supragingival therapy group (ST, n = 12) received supragingival scaling, whereas the intensive therapy group (IT, n = 12) underwent supra- and subgingival scaling, as well as root planing. Patients from both groups received professional oral hygiene instructions every month. Data regarding visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), probing pocket depth (PPD), clinical attachment level (CAL), serum levels of interleukin (IL)-6, IL-17A, IL-8, tumor necrosis factor α (TNF-α), monocyte chemoattractant protein (MCP)-1 enzyme-linked immunosorbent assay (ELISA), and glycated hemoglobin (HbA1c) levels were obtained at baseline and at 6 months post-therapy. Both therapies resulted in the improvement of almost all clinical periodontal parameters (p < 0.05). There were no differences in TNF-α, IL-8, IL-17A and HbA1c levels in either group (p >0.05), between the two periods. However, MCP-1 levels were significantly reduced in both the ST (p = 0.034) and the IT (p = 0.016) groups, whereas the serum IL-6 levels were significantly reduced only in the IT group (p = 0.001). Strict control of supragingival biofilm has a limited effect on systemic inflammatory markers, and a moderate effect on periodontal clinical parameters.info:eu-repo/semantics/openAccessSociedade Brasileira de Pesquisa Odontológica - SBPqOBrazilian Oral Research v.29 n.1 20152015-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242015000100266en10.1590/1807-3107BOR-2015.vol29.0071
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author ARTESE,Hilana Paula Carillo
LONGO,Priscila Larcher
GOMES,Giovane Hisse
MAYER,Marcia Pinto Alves
ROMITO,Giuseppe Alexandre
spellingShingle ARTESE,Hilana Paula Carillo
LONGO,Priscila Larcher
GOMES,Giovane Hisse
MAYER,Marcia Pinto Alves
ROMITO,Giuseppe Alexandre
Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
author_facet ARTESE,Hilana Paula Carillo
LONGO,Priscila Larcher
GOMES,Giovane Hisse
MAYER,Marcia Pinto Alves
ROMITO,Giuseppe Alexandre
author_sort ARTESE,Hilana Paula Carillo
title Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
title_short Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
title_full Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
title_fullStr Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
title_full_unstemmed Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
title_sort supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus
description The objective of this study was to evaluate the effect of strict supragingival biofilm control on serum inflammatory markers and on periodontal clinical parameters in type 2 diabetes mellitus (T2DM) patients with chronic severe periodontitis. Twenty-four individuals with T2DM and periodontitis were randomly allocated to two treatment groups. The supragingival therapy group (ST, n = 12) received supragingival scaling, whereas the intensive therapy group (IT, n = 12) underwent supra- and subgingival scaling, as well as root planing. Patients from both groups received professional oral hygiene instructions every month. Data regarding visible plaque index (VPI), gingival bleeding index (GBI), bleeding on probing (BOP), probing pocket depth (PPD), clinical attachment level (CAL), serum levels of interleukin (IL)-6, IL-17A, IL-8, tumor necrosis factor α (TNF-α), monocyte chemoattractant protein (MCP)-1 enzyme-linked immunosorbent assay (ELISA), and glycated hemoglobin (HbA1c) levels were obtained at baseline and at 6 months post-therapy. Both therapies resulted in the improvement of almost all clinical periodontal parameters (p < 0.05). There were no differences in TNF-α, IL-8, IL-17A and HbA1c levels in either group (p >0.05), between the two periods. However, MCP-1 levels were significantly reduced in both the ST (p = 0.034) and the IT (p = 0.016) groups, whereas the serum IL-6 levels were significantly reduced only in the IT group (p = 0.001). Strict control of supragingival biofilm has a limited effect on systemic inflammatory markers, and a moderate effect on periodontal clinical parameters.
publisher Sociedade Brasileira de Pesquisa Odontológica - SBPqO
publishDate 2015
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242015000100266
work_keys_str_mv AT artesehilanapaulacarillo supragingivalbiofilmcontrolandsystemicinflammationinpatientswithtype2diabetesmellitus
AT longopriscilalarcher supragingivalbiofilmcontrolandsystemicinflammationinpatientswithtype2diabetesmellitus
AT gomesgiovanehisse supragingivalbiofilmcontrolandsystemicinflammationinpatientswithtype2diabetesmellitus
AT mayermarciapintoalves supragingivalbiofilmcontrolandsystemicinflammationinpatientswithtype2diabetesmellitus
AT romitogiuseppealexandre supragingivalbiofilmcontrolandsystemicinflammationinpatientswithtype2diabetesmellitus
_version_ 1756431574800269312